69 related articles for article (PubMed ID: 9380408)
1. Identification of a second Grb2 binding site in the v-Fms tyrosine kinase.
Mancini A; Niedenthal R; Joos H; Koch A; Trouliaris S; Niemann H; Tamura T
Oncogene; 1997 Sep; 15(13):1565-72. PubMed ID: 9380408
[TBL] [Abstract][Full Text] [Related]
2. Phosphorylation of growth factor receptor binding protein-2 by pp60c-src tyrosine kinase.
Jones DA; Benjamin CW
Arch Biochem Biophys; 1997 Jan; 337(2):143-8. PubMed ID: 9016807
[TBL] [Abstract][Full Text] [Related]
3. Identification of Tyr-703 and Tyr-936 as the primary association sites for Grb2 and Grb7 in the c-Kit/stem cell factor receptor.
Thömmes K; Lennartsson J; Carlberg M; Rönnstrand L
Biochem J; 1999 Jul; 341 ( Pt 1)(Pt 1):211-6. PubMed ID: 10377264
[TBL] [Abstract][Full Text] [Related]
4. Crystal structures of the SH2 domain of Grb2: highlight on the binding of a new high-affinity inhibitor.
Nioche P; Liu WQ; Broutin I; Charbonnier F; Latreille MT; Vidal M; Roques B; Garbay C; Ducruix A
J Mol Biol; 2002 Feb; 315(5):1167-77. PubMed ID: 11827484
[TBL] [Abstract][Full Text] [Related]
5. Grb2 regulates Stat3 activation negatively in epidermal growth factor signalling.
Zhang T; Ma J; Cao X
Biochem J; 2003 Dec; 376(Pt 2):457-64. PubMed ID: 14498832
[TBL] [Abstract][Full Text] [Related]
6. The ETV6-NTRK3 gene fusion encodes a chimeric protein tyrosine kinase that transforms NIH3T3 cells.
Wai DH; Knezevich SR; Lucas T; Jansen B; Kay RJ; Sorensen PH
Oncogene; 2000 Feb; 19(7):906-15. PubMed ID: 10702799
[TBL] [Abstract][Full Text] [Related]
7. Bcr phosphorylated on tyrosine 177 binds Grb2.
Ma G; Lu D; Wu Y; Liu J; Arlinghaus RB
Oncogene; 1997 May; 14(19):2367-72. PubMed ID: 9178913
[TBL] [Abstract][Full Text] [Related]
8. Grb2 regulation of the actin-based cytoskeleton is required for ligand-independent EGF receptor-mediated oncogenesis.
Boerner JL; Danielsen AJ; Lovejoy CA; Wang Z; Juneja SC; Faupel-Badger JM; Darce JR; Maihle NJ
Oncogene; 2003 Oct; 22(43):6679-89. PubMed ID: 14555981
[TBL] [Abstract][Full Text] [Related]
9. Dynamin II associates with Grb2 SH3 domain in Ras transformed NIH3T3 cells.
Yoon SY; Koh WS; Lee MK; Park YM; Han MY
Biochem Biophys Res Commun; 1997 May; 234(3):539-43. PubMed ID: 9175747
[TBL] [Abstract][Full Text] [Related]
10. The amino-terminal Src homology 2 domain of phospholipase C gamma 1 is essential for TCR-induced tyrosine phosphorylation of phospholipase C gamma 1.
Stoica B; DeBell KE; Graham L; Rellahan BL; Alava MA; Laborda J; Bonvini E
J Immunol; 1998 Feb; 160(3):1059-66. PubMed ID: 9570517
[TBL] [Abstract][Full Text] [Related]
11. Suc1-associated neurotrophic factor target (SNT) protein is a major FGF-stimulated tyrosine phosphorylated 90-kDa protein which binds to the SH2 domain of GRB2.
Ong SH; Goh KC; Lim YP; Low BC; Klint P; Claesson-Welsh L; Cao X; Tan YH; Guy GR
Biochem Biophys Res Commun; 1996 Aug; 225(3):1021-6. PubMed ID: 8780727
[TBL] [Abstract][Full Text] [Related]
12. The C-terminal SH3 domain of the adapter protein Grb2 binds with high affinity to sequences in Gab1 and SLP-76 which lack the SH3-typical P-x-x-P core motif.
Lewitzky M; Kardinal C; Gehring NH; Schmidt EK; Konkol B; Eulitz M; Birchmeier W; Schaeper U; Feller SM
Oncogene; 2001 Mar; 20(9):1052-62. PubMed ID: 11314042
[TBL] [Abstract][Full Text] [Related]
13. Evidence for in vivo phosphorylation of the Grb2 SH2-domain binding site on focal adhesion kinase by Src-family protein-tyrosine kinases.
Schlaepfer DD; Hunter T
Mol Cell Biol; 1996 Oct; 16(10):5623-33. PubMed ID: 8816475
[TBL] [Abstract][Full Text] [Related]
14. Insulin-induced tyrosine phosphorylation of a M(r) 70,000 protein revealed by association with the Src homology 2 (SH2) and SH3 domains of p120GAP and Grb2.
Medema JP; Pronk GJ; de Vries-Smits AM; Clark R; McCormick F; Bos JL
Cell Growth Differ; 1996 Apr; 7(4):543-50. PubMed ID: 9052995
[TBL] [Abstract][Full Text] [Related]
15. Requirements for transformation by the fms oncogene product (CSF-1 receptor).
Rettenmier CW; Roussel MF; Wheeler EF; Sherr CJ
Princess Takamatsu Symp; 1986; 17():211-8. PubMed ID: 2843495
[TBL] [Abstract][Full Text] [Related]
16. Transforming potential of the c-fms proto-oncogene (CSF-1 receptor).
Roussel MF; Dull TJ; Rettenmier CW; Ralph P; Ullrich A; Sherr CJ
Nature; 1987 Feb 5-11; 325(6104):549-52. PubMed ID: 3027579
[TBL] [Abstract][Full Text] [Related]
17. Regulation by Gi2 proteins of v-fms-induced proliferation and transformation via Src-kinase and STAT3.
Corre I; Baumann H; Hermouet S
Oncogene; 1999 Nov; 18(46):6335-42. PubMed ID: 10597233
[TBL] [Abstract][Full Text] [Related]
18. Tyrosine phosphorylation of the juxtamembrane domain of the v-Fms oncogene product is required for its association with a 55-kDa protein.
Joos H; Trouliaris S; Helftenbein G; Niemann H; Tamura T
J Biol Chem; 1996 Oct; 271(40):24476-81. PubMed ID: 8798707
[TBL] [Abstract][Full Text] [Related]
19. The kinase activity of the v-fms encoded protein has a low pH optimum.
Lyman SD; Rohrschneider LR
Oncogene Res; 1989; 4(2):149-55. PubMed ID: 2654815
[TBL] [Abstract][Full Text] [Related]
20. Discovery of 3-aminobenzyloxycarbonyl as an N-terminal group conferring high affinity to the minimal phosphopeptide sequence recognized by the Grb2-SH2 domain.
Furet P; Gay B; García-Echeverría C; Rahuel J; Fretz H; Schoepfer J; Caravatti G
J Med Chem; 1997 Oct; 40(22):3551-6. PubMed ID: 9357522
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
